Merck & Co., Inc.'s (NYSE:MRK) Dismal Stock Performance Reflects Weak Fundamentals

Category: Finance

Merck's stock has declined 3.7% over the past three months, with a return on equity (ROE) of 5.7%, significantly below the industry average of 22%. The company's earnings have been shrinking, and its high payout ratio of 110% indicates it is depleting resources to maintain dividend payments. Analysts expect an improvement in ROE to 39% as the payout ratio drops to 32% over the next three years, but caution is advised due to the current unsatisfactory performance.

Keywords: Merck, Return on Equity, Earnings Growth

Source: Yahoo Finance

Update At: 7/30/2024

Related Sources